1Togawa D, govacic JJ, Lieberman IH, et al. Radiographic and histologic findings of vertebral augmentation using polymethylmethacrylate in the primate spine: percutaneous vertebroplasty and kyphoplasty [ J ]. Spine,2006,31:4 - 10.
2Hexig B, Nakaoka R, Tsuchiya T. Safety evaluation of surgical materials by cytotoxicity testing[ J]. J Artif Organs,2008,11:204 - 211.
3Ahn DK, Lee S, Choi D J, et al. Mechanical properties of blood-mixed polymethylmetacrylate in percutaneous vertebroplasty[ J]. Asian Spine J ,2009,3:45 - 52.
4Kane RJ, Yue W, Mason J J, et al. Improved fatigue life of acrylic bone cements reinforced with zirconia fibers [ J ]. J Mech Behav Biomed Mater,2010,3:504 - 511.
5Khaled SM, Charpentier Pa, Rizkalla AS. Synthesis and characteriza- tion of poly ( methyl methacrylate ) -based experimental bone cements reinforced with TiO2-SrO nanotubes[ J]. Acta Biomater,2010,6:3178 -3186.
7Tomita S, Kin A, Yazu M, et al. Biomechanieal evaluation of kyphoplasty and vertebroplasty with calcium phosphate cement in a simulated osteoporotic compression fracture [ J ]. J Orthop Sci, 2003,8 : 192 - 197.
8Heini PF, Berlemann U, Kaufmann M, et al. Augmentation of mechani- cal properties in osteoporotic vertebral bones:a biomechanical investi- gation of vertebroplasty efficacy with different bone cements [ J ]. Eur Spine J,2001,10 : 164 - 171.
9Kim EH, Shin DH, Nho JW, et al. Kyphoplasty with calcium phosphate cement (Calcibon (R))in osteoporotic vertebral fracture [ J]. J Korean Soc Spine Surg,2007,14:235 - 242.
1Varoga D, Drescher W, Pule M, et al. Differential expression of vascular endothelial growth factor in glucocorticoidrelated osteonecrosis of the femoral head [ J ]. Clin Orthop Relat Res ,2009,1:23.
2Kabata T, Matsumoto T, Yagishita S,et al. Vascular endo- thelial growth factor in rabbits during development of corticosteroid-induced osteonecrosis : a controlled experiment [ J ].J Rheumato1,2008,12:2383 - 2390.
3Qiu K, Zhao XJ, Wan CX,et al. Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds[ J]. Biomaterials,2006,8 : 1277 - 1286.
4Chen YW, Shi GQ, Ding YL,et al. In vitro study on the influence of strontium-doped calcium polyphosphate on the angiogenesis-reIated behaviors of HUVECs [ J ]. J Mater Sci Mater Med,2008 ,7 :2655 - 2662.
5Chen YW, Feng T, Shi GQ,et al. Interaction of endothelial cells with biodegradable strontium-doped calcium polyphosphate for bone tissue engineering [ J ]. Applied Surface Science,2008,2:331 - 335.
6Mont MA, Einhorn TA, Sponseller PD, et al. The trapdoor procedure using autogenous cortical and cancellous bone grafts for osteonecrosis of the femoral head[ J]. J Bone Joint Surg(Br) , 1998,1:56 - 62.
7Fen'ara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors [ J ]. Nat Med,2003 ,6 :669 - 676.
8Radke S, Battmann A, Jatzke S,et al. Expression of the an-giomatrix and angiogenic proteins CYR61, CTGF,and VEGF in osteonecrosis of the femoral head [ J ] .J Orthop Res, 2006,5:945 - 952.
9Kim HK, Bian H, Randall T, et al. Increased VEGF expression in the epiphyseal cartilage after ischemic necrosis of the capital femoral epiphysis [ J ]. J Bone Miner Res ,2004, 12 : 2041 - 2048.
10Mont MA, Jones LC, Hangerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later[J]. J Bone Joint Surg(Am) ,2006,5 : 1117 - 1132.
